Chronic Migraine Prophylaxis: Ultrasound-Guided Greater Occipital Nerve Block Versus Medical Treatment

Launched by TANTA UNIVERSITY · Nov 7, 2023

Keywords

ClinConnect Summary

This clinical trial is studying two different approaches to help prevent chronic migraines. Researchers want to see if an ultrasound-guided procedure called a greater occipital nerve block, which uses either a local anesthetic or botulinum toxin, is more effective than standard medical treatments. Chronic migraines can be very debilitating, and this trial aims to find out which method might give patients better relief from their symptoms.

To participate in the trial, you need to be over 18 years old and have a history of chronic migraines. However, if you have certain conditions, such as using too much headache medication or having specific injuries or reactions related to the treatment area, you may not be eligible. Participants will receive either the nerve block treatment or medical management and will be closely monitored for their migraine symptoms. If you're interested in helping researchers learn more about migraine prevention, this study could be a valuable opportunity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age \> 18 years old.
• • 2. Both sexes.
• • 3. Patients with chronic migraine.
• Exclusion Criteria:
• • 1. Age less than 18 years.
• • 2. Patients with medication overuse headache.
• • 3. Patients who had used acute pain medications within 24 hours prior to the study visit.
• • 4. History of injury to the area of the GON.
• • 5. Any prior adverse reactions to local anesthetics.
• • 6. Patients with impaired sensation in the occipital area.
• • 7. Any neurological or dermatological disease that may have affected skin sensation, bleeding tendency, any skull defect.